Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Swabb

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Reviews of Infectious Diseases|November 1, 1985
Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiencyF R Sattler, M Schramm, E A Swabb
Antimicrobial Agents and Chemotherapy|July 1, 1983
Pharmacology of aztreonam after intravenous infusionB E Scully, E A Swabb, H C Neu
Reviews of Infectious Diseases|November 1, 1985
Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infectionsE A Swabb, C O Cone, J G Muir
Antimicrobial Agents and Chemotherapy|January 1, 1984
Immunology of the monobactam aztreonamN F Adkinson, E A Swabb, A A Sugerman
Pharmacology & Therapeutics|January 1, 1985
Modern beta-lactam antibioticsR B Sykes, D P Bonner, E A Swabb
Antimicrobial Agents and Chemotherapy|August 1, 1984
Single-dose pharmacokinetics of aztreonam in pediatric patientsH R Stutman, M I Marks, E A Swabb
Antimicrobial Agents and Chemotherapy|January 1, 1983
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjectsE A Swabb, A A Sugerman, D N McKinstry
Reviews of Infectious Diseases|November 1, 1985
Summary of worldwide clinical trials of aztreonam in patients with urinary tract infectionsE A Swabb, S A Jenkins, J G Muir
Reviews of Infectious Diseases|November 1, 1985
Cross-allergenicity and immunogenicity of aztreonamN F Adkinson, A Saxon, M R Spence, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1984
Effect of aztreonam on throat and stool flora of cancer patientsP G Jones, G P Bodey, E A Swabb, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Reviews of Infectious Diseases|November 1, 1985
Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiencyF R Sattler, M Schramm, E A Swabb
Antimicrobial Agents and Chemotherapy|July 1, 1983
Pharmacology of aztreonam after intravenous infusionB E Scully, E A Swabb, H C Neu
Reviews of Infectious Diseases|November 1, 1985
Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infectionsE A Swabb, C O Cone, J G Muir
Antimicrobial Agents and Chemotherapy|January 1, 1984
Immunology of the monobactam aztreonamN F Adkinson, E A Swabb, A A Sugerman
Pharmacology & Therapeutics|January 1, 1985
Modern beta-lactam antibioticsR B Sykes, D P Bonner, E A Swabb
Antimicrobial Agents and Chemotherapy|August 1, 1984
Single-dose pharmacokinetics of aztreonam in pediatric patientsH R Stutman, M I Marks, E A Swabb
Antimicrobial Agents and Chemotherapy|January 1, 1983
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjectsE A Swabb, A A Sugerman, D N McKinstry
Reviews of Infectious Diseases|November 1, 1985
Summary of worldwide clinical trials of aztreonam in patients with urinary tract infectionsE A Swabb, S A Jenkins, J G Muir
Reviews of Infectious Diseases|November 1, 1985
Cross-allergenicity and immunogenicity of aztreonamN F Adkinson, A Saxon, M R Spence, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1984
Effect of aztreonam on throat and stool flora of cancer patientsP G Jones, G P Bodey, E A Swabb, et al.
Pageof 4